Andrea T. Hooper

Regeneron (United States) — United States

Medicine · Health Sciences

40h-index12.4kcitations189works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(39), SARS-CoV-2 and COVID-19 Research(37), COVID-19 Clinical Research Studies(32), CAR-T cell therapy research(30), Angiogenesis and VEGF in Cancer(28)

Publications188 total

Concerted changes in the pediatric single-cell intestinal ecosystem before and after anti-TNF blockade
2025· 1 citedOpen Access
Author response: Concerted changes in the pediatric single-cell intestinal ecosystem before and after anti-TNF blockade
2025Open Access
Longitudinal multiproteomic analysis reveals persistent underlying inflammation in acute graft-versus-host disease patients responding to corticosteroid treatment
Blood·2025Open Access
Comprehensive multiproteomic analysis reveals an inflammatory phenotype in immune aplastic anemia characterized by broad activation of antigen presenting cells and t helper/cytotoxic 1.17 immune responses
Blood·2025Open Access
Unraveling the Dynamic Interplay of SARS-CoV-2 Neutralizing Monoclonal Antibodies and Host Immunity in Hospitalized Patients with COVID-19 2264
The Journal of Immunology·2025Open Access
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma
Science Translational Medicine·2025· 4 cited
Divergent T Cell Phenotypes Define Pediatric Crohn’s Disease and Ulcerative Colitis
2025· 1 citedOpen Access
From mice to humans: Pathway analysis uncovers shared and distinct effects of IL-33 versus IL-4Rα blockade in asthma
2025
SARS-CoV-2 vaccine failure rates and predictors of immune response in a diverse immunocompromised patient population
Vaccine·2025· 1 citedOpen Access
Supplementary Table S6 from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
Data from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
Supplementary Table S7 from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
Supplementary Table S4 from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
Supplementary Table S11 from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
Supplementary Table S12 from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
Supplementary Figure S7 from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
Supplementary Table S9 from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
Supplementary Figure S2 from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
Supplementary Table S14 from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
Supplementary Table S13 from A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies
2025Open Access
page 1 of 10Next →

Frequent Co-authors

Shahin Rafii(18), Daniel J. Hicklin(13), George D. Yancopoulos(10), Jennifer D. Hamilton(9), Gary Herman(8), Adnan Mahmood(7), K. C. Turner(7), Peter Böhlen(7), Hans‐Georg Kopp(7), Bret J. Musser(6), Alina Baum(6), Christos A. Kyratsous(6), Bari Kowal(6), Neil Stahl(6), Leah Lipsich(6), Ned Braunstein(6), Yan Wu(6), Sergey V. Shmelkov(6), Eduardo Forleo‐Neto(6), David M. Weinreich(6)